333-184441 SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
By Atsuko Fukase And Eric Pfanner TOKYO--Otsuka Pharmaceutical Co. agreed to buy Avanir Pharmaceuticals Inc. of the U.S. for $3.5 billion, the...
Japanese drug maker Otsuka Pharmaceutical Co. has agreed to buy California-based Avanir Pharmaceuticals Inc. in a deal that values the...
As filed with the Securities and Exchange Commission on October 16, 2014 Registration No...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...
WASHINGTON--The U.S. Supreme Court on Monday refused to consider a generic drug maker's challenge to Otsuka Pharmaceutical Co.'s U.S. patent for...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads